Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU device definition

This article was originally published in The Gray Sheet

Executive Summary

European Parliament votes Oct. 2 to define pharmaceuticals as substances that may be "used in" human beings instead of "administered to," as proposed in original pharmaceutical directive review legislation. The words "by exerting a pharmacological action" have been added, however, and Eucomed will lobby to insert "as primary mode of action" into the text. European industry reps have been wary of the definition since summer, when concerns first surfaced that combination products would automatically be legislated as drugs (1"The Gray Sheet" June 24, 2002, p. 12)...

You may also be interested in...



EU Industry Still Wary Of Borderline Devices After Positive Parliament Vote

The European Parliament's device-supporting plenary session vote Oct. 23 in Strasbourg largely rejects the suggested primacy of the revised Directive 2001/83/EC on the Community Code relating to Medicinal Products for Human Use over the Medical Devices Directive

MDA Merger Qualms Fuel Device Industry Critique Of EU Drug Directive

The medical device industry is steadily mounting resistance to the European Union's planned revisions to Directive 2001/83/EC on Medicinal Products for Human Use

APACMed 2020: Healthineers Evolves Therapy Remit And Makes All Asia An Equal Priority

Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel